| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.697 | 0.007 | 0.811 | 5 Hydroxytryptamine release stimulant | 0.653 0.01 CID_10688629 0.7 0.007 CID_18986923 0.707 0.007 CID_71374942 0.811 0.003 CID_10710332 | CID_10710332 | |
| 0.651 | 0.005 | 0.657 | Vasodilator, coronary | 0.636 0.006 CID_10688629 0.657 0.005 CID_18986923 0.655 0.005 CID_71374942 0.593 0.008 CID_10710332 | CID_18986923 | |
| 0.633 | 0.015 | 0.747 | Aldehyde oxidase inhibitor | 0.722 0.007 CID_10688629 0.743 0.005 CID_18986923 0.747 0.005 CID_71374942 0.338 0.058 CID_10710332 | CID_71374942 | |
| 0.59 | 0.014 | 0.649 | Spasmolytic | 0.649 0.009 CID_10688629 0.62 0.011 CID_18986923 0.629 0.01 CID_71374942 0.417 0.037 CID_10710332 | CID_10688629 | |
| 0.549 | 0.003 | 0.549 | Sigma 1 receptor antagonist | 0.457 0.004 CID_10688629 0.423 0.004 CID_18986923 0.413 0.004 CID_71374942 0.239 0.004 CID_10710332 | ||
| 0.58 | 0.039 | 0.669 | Caspase 9 stimulant | 0.586 0.038 CID_10688629 0.669 0.028 CID_18986923 0.665 0.028 CID_71374942 0.431 0.093 CID_10710332 | CID_18986923 | |
| 0.54 | 0.011 | 0.54 | Cardiotonic | 0.525 0.013 CID_10688629 0.484 0.017 CID_18986923 0.477 0.018 CID_71374942 0.361 0.036 CID_10710332 | ||
| 0.499 | 0.008 | 0.533 | Anesthetic general | 0.532 0.006 CID_10688629 0.528 0.006 CID_18986923 0.533 0.006 CID_71374942 0.31 0.031 CID_10710332 | CID_71374942 | |
| 0.484 | 0.006 | 0.484 | Calcium channel activator | 0.421 0.018 CID_10688629 0.466 0.008 CID_18986923 0.469 0.008 CID_71374942 0.48 0.007 CID_10710332 | ||
| 0.461 | 0.003 | 0.461 | Calcium antagonist | 0.278 0.006 CID_10688629 0.308 0.004 CID_18986923 0.314 0.004 CID_71374942 0.376 0.004 CID_10710332 | ||
| 0.486 | 0.031 | 0.531 | Vasodilator, peripheral | 0.502 0.027 CID_10688629 0.495 0.029 CID_18986923 0.492 0.029 CID_71374942 0.531 0.023 CID_10710332 | CID_10710332 | |
| 0.486 | 0.035 | 0.595 | Cholesterol antagonist | 0.595 0.019 CID_10688629 0.563 0.023 CID_18986923 0.557 0.024 CID_71374942 0.443 0.042 CID_10710332 | CID_10688629 | |
| 0.452 | 0.021 | 0.539 | Antiamyloidogenic | 0.504 0.015 CID_10688629 0.539 0.013 CID_18986923 0.533 0.013 CID_71374942 0.41 0.027 CID_10710332 | CID_18986923 | |
| 0.445 | 0.017 | 0.48 | Vasodilator | 0.48 0.014 CID_10688629 0.446 0.017 CID_18986923 0.437 0.018 CID_71374942 0.366 0.029 CID_10710332 | CID_10688629 | |
| 0.431 | 0.005 | 0.431 | Sigma receptor antagonist | 0.376 0.005 CID_10688629 0.348 0.005 CID_18986923 0.341 0.005 CID_71374942 0.166 0.01 CID_10710332 | ||
| 0.431 | 0.005 | 0.442 | Anesthetic local | 0.442 0.005 CID_10688629 0.379 0.007 CID_18986923 0.39 0.007 CID_71374942 0.294 0.013 CID_10710332 | CID_10688629 | |
| 0.42 | 0.022 | 0.511 | Amyloid beta aggregation inhibitor | 0.511 0.013 CID_10688629 0.481 0.016 CID_18986923 0.475 0.016 CID_71374942 0.372 0.03 CID_10710332 | CID_10688629 | |
| 0.403 | 0.022 | 0.403 | Psychostimulant | 0.403 0.022 CID_10688629 0.395 0.023 CID_18986923 0.401 0.022 CID_71374942 0.365 0.029 CID_10710332 | ||
| 0.386 | 0.029 | 0.456 | Superoxide dismutase inhibitor | 0.453 0.018 CID_10688629 0.451 0.019 CID_18986923 0.456 0.018 CID_71374942 0.446 0.019 CID_10710332 | CID_71374942 | |
| 0.408 | 0.073 | 0.423 | 5 Hydroxytryptamine release inhibitor | 0.397 0.08 CID_10688629 0.422 0.065 CID_18986923 0.423 0.065 CID_71374942 0.359 0.107 CID_10710332 | CID_71374942 | |
| 0.353 | 0.025 | 0.365 | Cyclic AMP phosphodiesterase inhibitor | 0.363 0.023 CID_10688629 0.365 0.022 CID_18986923 0.357 0.024 CID_71374942 0.164 0.129 CID_10710332 | CID_18986923 | |
| 0.331 | 0.007 | 0.331 | Calcium channel blocker | 0.216 0.024 CID_10688629 0.23 0.021 CID_18986923 0.236 0.02 CID_71374942 0.26 0.015 CID_10710332 | ||
| 0.343 | 0.031 | 0.343 | Sigma receptor agonist | 0.23 0.053 CID_10688629 0.328 0.034 CID_18986923 0.335 0.033 CID_71374942 0.143 0.09 CID_10710332 | ||
| 0.332 | 0.021 | 0.436 | Tyrosine 3 hydroxylase inhibitor | 0.436 0.005 CID_10688629 0.397 0.008 CID_18986923 0.398 0.008 CID_71374942 0.302 0.032 CID_10710332 | CID_10688629 | |
| 0.343 | 0.04 | 0.343 | Tumour necrosis factor alpha release inhibitor | 0.31 0.049 CID_10688629 0.326 0.045 CID_18986923 0.319 0.047 CID_71374942 0.227 0.087 CID_10710332 | ||
| 0.33 | 0.032 | 0.379 | 5 Hydroxytryptamine uptake stimulant | 0.379 0.018 CID_10688629 0.31 0.04 CID_18986923 0.313 0.039 CID_71374942 0.335 0.03 CID_10710332 | CID_10688629 | |
| 0.311 | 0.027 | 0.311 | P-glycoprotein inhibitor | 0.269 0.036 CID_10688629 0.291 0.031 CID_18986923 0.288 0.031 CID_71374942 0.249 0.041 CID_10710332 | ||
| 0.287 | 0.004 | 0.287 | Sphingomyelinase inhibitor | 0.239 0.005 CID_10688629 0.249 0.004 CID_18986923 0.251 0.004 CID_71374942 0.219 0.007 CID_10710332 | ||
| 0.319 | 0.048 | 0.359 | Insulysin inhibitor | 0.359 0.031 CID_10688629 0.337 0.039 CID_18986923 0.339 0.039 CID_71374942 0.275 0.075 CID_10710332 | CID_10688629 | |
| 0.345 | 0.078 | 0.451 | Transcription factor NF kappa B inhibitor | 0.435 0.056 CID_10688629 0.451 0.053 CID_18986923 0.448 0.053 CID_71374942 0.36 0.074 CID_10710332 | CID_18986923 | |
| 0.269 | 0.004 | 0.269 | Calcium channel L-type blocker | 0.183 0.006 CID_10688629 0.191 0.006 CID_18986923 0.196 0.005 CID_71374942 0.189 0.006 CID_10710332 | ||
| 0.33 | 0.072 | 0.403 | Antithrombotic | 0.403 0.048 CID_10688629 0.365 0.059 CID_18986923 0.358 0.061 CID_71374942 0.271 0.11 CID_10710332 | CID_10688629 | |
| 0.27 | 0.019 | 0.27 | Nav1.2 sodium channel blocker | 0.208 0.032 CID_10688629 0.207 0.032 CID_18986923 0.214 0.03 CID_71374942 0.215 0.029 CID_10710332 | ||
| 0.266 | 0.015 | 0.314 | Cholesterol synthesis inhibitor | 0.313 0.01 CID_10688629 0.314 0.01 CID_18986923 0.308 0.01 CID_71374942 0.122 0.063 CID_10710332 | CID_18986923 | |
| 0.27 | 0.025 | 0.325 | Insulin sensitizer | 0.307 0.014 CID_10688629 0.281 0.021 CID_18986923 0.281 0.021 CID_71374942 0.325 0.012 CID_10710332 | CID_10710332 | |
| 0.251 | 0.013 | 0.251 | Dopamine D2 antagonist | 0.221 0.015 CID_10688629 0.213 0.016 CID_18986923 0.222 0.015 CID_71374942 0.15 0.023 CID_10710332 | ||
| 0.261 | 0.026 | 0.302 | MAO inhibitor | 0.295 0.021 CID_10688629 0.292 0.021 CID_18986923 0.302 0.02 CID_71374942 0.187 0.045 CID_10710332 | CID_71374942 | |
| 0.28 | 0.045 | 0.28 | 5 Hydroxytryptamine 1E antagonist | 0.261 0.063 CID_10688629 0.268 0.056 CID_18986923 0.268 0.056 CID_71374942 0.259 0.065 CID_10710332 | ||
| 0.284 | 0.059 | 0.353 | Hypoglycemic | 0.353 0.037 CID_10688629 0.33 0.043 CID_18986923 0.321 0.046 CID_71374942 0.329 0.043 CID_10710332 | CID_10688629 | |
| 0.244 | 0.022 | 0.244 | Acetylcholinesterase inhibitor | 0.212 0.03 CID_10688629 0.218 0.028 CID_18986923 0.217 0.028 CID_71374942 0.193 0.035 CID_10710332 | ||
| 0.223 | 0.005 | 0.287 | Prolactin inhibitor | 0.287 0.003 CID_10688629 0.26 0.004 CID_18986923 0.263 0.004 CID_71374942 0.119 0.039 CID_10710332 | CID_10688629 | |
| 0.24 | 0.026 | 0.289 | Phospholipase A2 inhibitor | 0.289 0.015 CID_10688629 0.263 0.02 CID_18986923 0.265 0.02 CID_71374942 0.241 0.026 CID_10710332 | CID_10688629 | |
| 0.227 | 0.016 | 0.227 | Dopamine antagonist | 0.204 0.018 CID_10688629 0.191 0.02 CID_18986923 0.2 0.019 CID_71374942 0.139 0.028 CID_10710332 | ||
| 0.229 | 0.019 | 0.355 | Antiadrenergic | 0.208 0.023 CID_10688629 0.198 0.025 CID_18986923 0.196 0.025 CID_71374942 0.355 0.01 CID_10710332 | CID_10710332 | |
| 0.231 | 0.024 | 0.28 | MAO A inhibitor | 0.271 0.018 CID_10688629 0.27 0.018 CID_18986923 0.28 0.017 CID_71374942 0.179 0.034 CID_10710332 | CID_71374942 | |
| 0.269 | 0.061 | 0.43 | Free radical scavenger | 0.43 0.024 CID_10688629 0.387 0.031 CID_18986923 0.38 0.033 CID_71374942 0.278 0.058 CID_10710332 | CID_10688629 | |
| 0.224 | 0.019 | 0.224 | Alpha 2b adrenoreceptor antagonist | 0.172 0.031 CID_10688629 0.177 0.03 CID_18986923 0.184 0.028 CID_71374942 0.168 0.032 CID_10710332 | ||
| 0.205 | 0.004 | 0.287 | Beta 3 adrenoreceptor antagonist | 0.287 0.003 CID_10688629 0.276 0.003 CID_18986923 0.278 0.003 CID_71374942 0.255 0.003 CID_10710332 | CID_10688629 | |
| 0.221 | 0.02 | 0.351 | Adrenaline antagonist | 0.2 0.023 CID_10688629 0.191 0.025 CID_18986923 0.189 0.026 CID_71374942 0.351 0.01 CID_10710332 | CID_10710332 | |
| 0.223 | 0.023 | 0.223 | 5 Hydroxytryptamine 2B antagonist | 0.133 0.05 CID_10688629 0.149 0.041 CID_18986923 0.154 0.039 CID_71374942 0.121 0.06 CID_10710332 | ||
| 0.214 | 0.015 | 0.214 | Alpha 2c adrenoreceptor antagonist | 0.17 0.025 CID_10688629 0.175 0.023 CID_18986923 0.182 0.022 CID_71374942 0.185 0.021 CID_10710332 | ||
| 0.219 | 0.02 | 0.251 | Acetylcholine muscarinic antagonist | 0.251 0.014 CID_10688629 0.223 0.019 CID_18986923 0.228 0.018 CID_71374942 0.185 0.028 CID_10710332 | CID_10688629 | |
| 0.213 | 0.015 | 0.213 | Nav1.6 sodium channel blocker | 0.171 0.034 CID_10688629 0.173 0.033 CID_18986923 0.174 0.032 CID_71374942 0.155 0.049 CID_10710332 | ||
| 0.27 | 0.074 | 0.416 | Antioxidant | 0.416 0.032 CID_10688629 0.374 0.04 CID_18986923 0.366 0.042 CID_71374942 0.266 0.076 CID_10710332 | CID_10688629 | |
| 0.199 | 0.004 | 0.297 | Beta adrenoreceptor antagonist | 0.268 0.003 CID_10688629 0.256 0.003 CID_18986923 0.255 0.003 CID_71374942 0.297 0.003 CID_10710332 | CID_10710332 | |
| 0.201 | 0.01 | 0.294 | Dopamine agonist | 0.294 0.005 CID_10688629 0.208 0.009 CID_18986923 0.204 0.009 CID_71374942 0.171 0.013 CID_10710332 | CID_10688629 | |
| 0.206 | 0.017 | 0.216 | Cyclooxygenase 3 inhibitor | 0.213 0.015 CID_10688629 0.214 0.014 CID_18986923 0.216 0.014 CID_71374942 0.199 0.019 CID_10710332 | CID_71374942 | |
| 0.207 | 0.023 | 0.232 | MAO B inhibitor | 0.229 0.019 CID_10688629 0.225 0.02 CID_18986923 0.232 0.019 CID_71374942 0.137 0.042 CID_10710332 | CID_71374942 | |
| 0.196 | 0.013 | 0.217 | Vanilloid 1 agonist | 0.211 0.009 CID_10688629 0.217 0.009 CID_18986923 0.216 0.009 CID_71374942 0.202 0.011 CID_10710332 | CID_18986923 | |
| 0.181 | 0.004 | 0.301 | Beta 1 adrenoreceptor antagonist | 0.233 0.003 CID_10688629 0.222 0.003 CID_18986923 0.22 0.003 CID_71374942 0.301 0.003 CID_10710332 | CID_10710332 | |
| 0.186 | 0.01 | 0.186 | Electron transport complex I inhibitor | 0.157 0.017 CID_10688629 0.171 0.013 CID_18986923 0.168 0.014 CID_71374942 0.178 0.011 CID_10710332 | ||
| 0.245 | 0.07 | 0.28 | Hypolipemic | 0.28 0.055 CID_10688629 0.253 0.066 CID_18986923 0.247 0.068 CID_71374942 0.2 0.094 CID_10710332 | CID_10688629 | |
| 0.216 | 0.041 | 0.216 | 5 Hydroxytryptamine 3E antagonist | 0.205 0.054 CID_10688629 0.166 0.15 CID_18986923 0.167 0.145 CID_71374942 0.215 0.042 CID_10710332 | ||
| 0.178 | 0.004 | 0.178 | Sigma 2 receptor antagonist | 0.107 0.005 CID_10688629 0.161 0.004 CID_18986923 0.173 0.004 CID_71374942 0.072 0.006 CID_10710332 | ||
| 0.204 | 0.031 | 0.224 | Cholinergic antagonist | 0.224 0.026 CID_10688629 0.197 0.033 CID_18986923 0.2 0.032 CID_71374942 0.17 0.043 CID_10710332 | CID_10688629 | |
| 0.211 | 0.042 | 0.211 | Cholinergic | 0.171 0.061 CID_10688629 0.175 0.059 CID_18986923 0.174 0.06 CID_71374942 0.154 0.074 CID_10710332 | ||
| 0.172 | 0.003 | 0.172 | Calcium channel P-type blocker | 0.098 0.006 CID_10688629 0.123 0.004 CID_18986923 0.126 0.004 CID_71374942 0.105 0.005 CID_10710332 | ||
| 0.187 | 0.02 | 0.187 | Calcium channel (voltage-sensitive) blocker | 0.123 0.053 CID_10688629 0.121 0.055 CID_18986923 0.123 0.053 CID_71374942 0.134 0.043 CID_10710332 | ||
| 0.198 | 0.031 | 0.217 | Acetylcholine antagonist | 0.217 0.027 CID_10688629 0.191 0.033 CID_18986923 0.193 0.032 CID_71374942 0.167 0.042 CID_10710332 | CID_10688629 | |
| 0.257 | 0.09 | 0.264 | Ca(v)3.3 blocker | 0.264 0.08 CID_10710332 | CID_10710332 | |
| 0.183 | 0.016 | 0.183 | 5 Hydroxytryptamine 1A antagonist | 0.081 0.04 CID_10688629 0.107 0.029 CID_18986923 0.113 0.028 CID_71374942 0.133 0.023 CID_10710332 | ||
| 0.204 | 0.041 | 0.243 | Acetylcholine M1 receptor antagonist | 0.243 0.027 CID_10688629 0.208 0.039 CID_18986923 0.209 0.038 CID_71374942 0.17 0.059 CID_10710332 | CID_10688629 | |
| 0.272 | 0.109 | 0.272 | Thyroid hormone antagonist | 0.269 0.112 CID_10688629 0.26 0.117 CID_18986923 0.261 0.116 CID_71374942 0.234 0.134 CID_10710332 | ||
| 0.194 | 0.031 | 0.212 | Neurotrophic factor | 0.212 0.023 CID_10688629 0.192 0.031 CID_18986923 0.189 0.033 CID_71374942 0.167 0.046 CID_10710332 | CID_10688629 | |
| 0.191 | 0.028 | 0.191 | Nav1.3 sodium channel blocker | 0.139 0.055 CID_10688629 0.138 0.057 CID_18986923 0.141 0.054 CID_71374942 0.16 0.042 CID_10710332 | ||
| 0.17 | 0.008 | 0.2 | Myeloperoxidase inhibitor | 0.2 0.005 CID_10688629 0.19 0.006 CID_18986923 0.193 0.005 CID_71374942 0.198 0.005 CID_10710332 | CID_10688629 | |
| 0.221 | 0.059 | 0.277 | Nitric-oxide synthase stimulant | 0.244 0.037 CID_10688629 0.244 0.037 CID_18986923 0.236 0.044 CID_71374942 0.277 0.018 CID_10710332 | CID_10710332 | |
| 0.177 | 0.017 | 0.177 | Gastric antisecretory | 0.153 0.025 CID_10688629 0.15 0.027 CID_18986923 0.154 0.025 CID_71374942 0.177 0.017 CID_10710332 | ||
| 0.165 | 0.005 | 0.165 | 5 Hydroxytryptamine 2A agonist | 0.107 0.012 CID_10688629 0.149 0.005 CID_18986923 0.149 0.005 CID_71374942 0.148 0.005 CID_10710332 | ||
| 0.181 | 0.022 | 0.286 | Bronchodilator | 0.17 0.025 CID_10688629 0.189 0.02 CID_18986923 0.185 0.021 CID_71374942 0.286 0.01 CID_10710332 | CID_10710332 | |
| 0.217 | 0.059 | 0.222 | Non-steroidal antiinflammatory agent | 0.218 0.058 CID_10688629 0.222 0.056 CID_18986923 0.222 0.056 CID_71374942 0.15 0.114 CID_10710332 | CID_71374942 | |
| 0.191 | 0.033 | 0.191 | 5 Hydroxytryptamine 2 antagonist | 0.099 0.072 CID_10688629 0.11 0.065 CID_18986923 0.115 0.062 CID_71374942 0.127 0.055 CID_10710332 | ||
| 0.176 | 0.019 | 0.176 | 5 Hydroxytryptamine 1 antagonist | 0.073 0.051 CID_10688629 0.097 0.038 CID_18986923 0.103 0.036 CID_71374942 0.127 0.028 CID_10710332 | ||
| 0.162 | 0.006 | 0.162 | 5 Hydroxytryptamine 5A antagonist | 0.115 0.013 CID_10688629 0.118 0.012 CID_18986923 0.124 0.011 CID_71374942 0.089 0.019 CID_10710332 | ||
| 0.161 | 0.007 | 0.161 | 5 Hydroxytryptamine 5 antagonist | 0.1 0.015 CID_10688629 0.111 0.013 CID_18986923 0.118 0.012 CID_71374942 0.086 0.018 CID_10710332 | ||
| 0.179 | 0.025 | 0.204 | Sphingosine 1-phosphate receptor 5 antagonist | 0.204 0.01 CID_10688629 0.174 0.029 CID_18986923 0.173 0.031 CID_71374942 0.184 0.02 CID_10710332 | CID_10688629 | |
| 0.164 | 0.012 | 0.274 | Adrenaline agonist | 0.258 0.004 CID_10688629 0.226 0.005 CID_18986923 0.227 0.005 CID_71374942 0.274 0.004 CID_10710332 | CID_10710332 | |
| 0.164 | 0.014 | 0.164 | 5 Hydroxytryptamine 1F antagonist | 0.124 0.022 CID_10688629 0.112 0.026 CID_18986923 0.113 0.026 CID_71374942 0.068 0.051 CID_10710332 | ||
| 0.264 | 0.114 | 0.322 | Sodium/bile acid cotransporter inhibitor | 0.305 0.075 CID_10688629 0.322 0.06 CID_18986923 0.321 0.061 CID_71374942 0.281 0.097 CID_10710332 | CID_18986923 | |
| 0.175 | 0.026 | 0.175 | Butyrylcholinesterase inhibitor | 0.146 0.035 CID_10688629 0.143 0.037 CID_18986923 0.144 0.036 CID_71374942 0.157 0.032 CID_10710332 | ||
| 0.154 | 0.006 | 0.251 | Dopamine D2 agonist | 0.251 0.005 CID_10688629 0.171 0.005 CID_18986923 0.166 0.006 CID_71374942 0.132 0.008 CID_10710332 | CID_10688629 | |
| 0.176 | 0.029 | 0.225 | Adenylate cyclase stimulant | 0.225 0.006 CID_10688629 0.199 0.014 CID_18986923 0.195 0.016 CID_71374942 0.205 0.012 CID_10710332 | CID_10688629 | |
| 0.192 | 0.045 | 0.298 | Lipid peroxidase inhibitor | 0.298 0.019 CID_10688629 0.262 0.025 CID_18986923 0.254 0.026 CID_71374942 0.175 0.053 CID_10710332 | CID_10688629 | |
| 0.178 | 0.031 | 0.178 | Alpha adrenoreceptor antagonist | 0.106 0.053 CID_10688629 0.122 0.046 CID_18986923 0.129 0.044 CID_71374942 0.167 0.033 CID_10710332 | ||
| 0.17 | 0.022 | 0.17 | 5 Hydroxytryptamine 2C antagonist | 0.084 0.058 CID_10688629 0.1 0.045 CID_18986923 0.103 0.044 CID_71374942 0.134 0.031 CID_10710332 | ||
| 0.158 | 0.011 | 0.161 | Peroxisome proliferator-activated receptor gamma agonist | 0.161 0.01 CID_10688629 0.147 0.014 CID_18986923 0.144 0.014 CID_71374942 0.131 0.017 CID_10710332 | CID_10688629 | |
| 0.159 | 0.012 | 0.16 | Acetylcholine release stimulant | 0.116 0.054 CID_10688629 0.127 0.038 CID_18986923 0.129 0.036 CID_71374942 0.16 0.012 CID_10710332 | CID_10710332 | |
| 0.26 | 0.118 | 0.318 | Apoptosis antagonist | 0.318 0.074 CID_10688629 0.299 0.086 CID_18986923 0.296 0.088 CID_71374942 0.273 0.106 CID_10710332 | CID_10688629 | |
| 0.144 | 0.003 | 0.144 | Plasmepsin II inhibitor | 0.107 0.004 CID_10688629 0.122 0.004 CID_18986923 0.124 0.004 CID_71374942 0.096 0.005 CID_10710332 | ||
| 0.144 | 0.004 | 0.185 | Estrogen-related receptor beta agonist | 0.171 0.003 CID_10688629 0.183 0.003 CID_18986923 0.185 0.003 CID_71374942 0.162 0.004 CID_10710332 | CID_71374942 | |
| 0.184 | 0.046 | 0.21 | Neurotensin receptor agonist | 0.181 0.049 CID_10688629 0.21 0.03 CID_18986923 0.209 0.031 CID_71374942 0.207 0.031 CID_10710332 | CID_18986923 | |
| 0.149 | 0.013 | 0.162 | Interleukin 12 antagonist | 0.156 0.011 CID_10688629 0.162 0.009 CID_18986923 0.162 0.009 CID_71374942 0.14 0.016 CID_10710332 | CID_71374942 | |
| 0.146 | 0.011 | 0.161 | Histamine H2 receptor antagonist | 0.128 0.017 CID_10688629 0.109 0.027 CID_18986923 0.11 0.027 CID_71374942 0.161 0.008 CID_10710332 | CID_10710332 | |
| 0.251 | 0.118 | 0.251 | Thyroid hormone beta antagonist | 0.233 0.129 CID_10688629 0.229 0.132 CID_18986923 0.231 0.131 CID_71374942 0.218 0.14 CID_10710332 | ||
| 0.138 | 0.005 | 0.24 | Beta 2 adrenoreceptor antagonist | 0.213 0.003 CID_10688629 0.185 0.004 CID_18986923 0.184 0.004 CID_71374942 0.24 0.003 CID_10710332 | CID_10710332 | |
| 0.214 | 0.083 | 0.276 | Peptidyltransferase inhibitor | 0.269 0.038 CID_10688629 0.246 0.054 CID_18986923 0.243 0.056 CID_71374942 0.276 0.035 CID_10710332 | CID_10710332 | |
| 0.302 | 0.171 | 0.373 | Apoptosis agonist | 0.37 0.128 CID_10688629 0.373 0.127 CID_18986923 0.369 0.129 CID_71374942 0.256 0.208 CID_10710332 | CID_18986923 | |
| 0.14 | 0.012 | 0.19 | Acetylcholine M3 receptor antagonist | 0.19 0.007 CID_10688629 0.175 0.009 CID_18986923 0.18 0.008 CID_71374942 0.142 0.012 CID_10710332 | CID_10688629 | |
| 0.155 | 0.029 | 0.201 | Sphingosine 1-phosphate receptor 4 antagonist | 0.144 0.039 CID_10688629 0.139 0.044 CID_18986923 0.139 0.044 CID_71374942 0.201 0.009 CID_10710332 | CID_10710332 | |
| 0.263 | 0.139 | 0.309 | Immunosuppressant | 0.309 0.109 CID_10688629 0.298 0.116 CID_18986923 0.292 0.12 CID_71374942 0.259 0.141 CID_10710332 | CID_10688629 | |
| 0.203 | 0.079 | 0.203 | Platelet aggregation inhibitor | 0.159 0.119 CID_18986923 0.155 0.122 CID_71374942 0.163 0.114 CID_10710332 | ||
| 0.131 | 0.008 | 0.131 | Peroxisome proliferator-activated receptor alpha agonist | 0.122 0.009 CID_10688629 0.116 0.009 CID_18986923 0.115 0.009 CID_71374942 0.079 0.018 CID_10710332 | ||
| 0.149 | 0.027 | 0.149 | Alpha 2 adrenoreceptor antagonist | 0.122 0.036 CID_10688629 0.113 0.04 CID_18986923 0.118 0.038 CID_71374942 0.108 0.042 CID_10710332 | ||
| 0.262 | 0.141 | 0.326 | Calpain 2 inhibitor | 0.194 0.193 CID_10688629 0.2 0.187 CID_71374942 0.326 0.099 CID_10710332 | CID_10710332 | |
| 0.232 | 0.113 | 0.337 | Lipoxygenase inhibitor | 0.337 0.055 CID_10688629 0.322 0.061 CID_18986923 0.327 0.059 CID_71374942 0.232 0.112 CID_10710332 | CID_10688629 | |
| 0.263 | 0.146 | 0.403 | Histamine release inhibitor | 0.403 0.074 CID_10688629 0.332 0.108 CID_18986923 0.335 0.106 CID_71374942 | CID_10688629 | |
| 0.154 | 0.038 | 0.154 | Interleukin 1b antagonist | 0.106 0.074 CID_10688629 0.131 0.054 CID_18986923 0.131 0.054 CID_71374942 | ||
| 0.234 | 0.119 | 0.338 | 12-Lipoxygenase inhibitor | 0.338 0.061 CID_10688629 0.327 0.066 CID_18986923 0.332 0.064 CID_71374942 0.263 0.102 CID_10710332 | CID_10688629 | |
| 0.157 | 0.043 | 0.226 | Aldehyde dehydrogenase inhibitor | 0.206 0.026 CID_10688629 0.224 0.023 CID_18986923 0.226 0.022 CID_71374942 0.137 0.056 CID_10710332 | CID_71374942 | |
| 0.125 | 0.013 | 0.125 | Granulocyte macrophage colony stimulating factor agonist | 0.118 0.017 CID_10688629 0.118 0.017 CID_18986923 0.119 0.016 CID_71374942 0.118 0.017 CID_10710332 | ||
| 0.176 | 0.072 | 0.209 | Succinate dehydrogenase inhibitor | 0.209 0.042 CID_10688629 0.187 0.06 CID_18986923 0.185 0.063 CID_71374942 0.182 0.065 CID_10710332 | CID_10688629 | |
| 0.112 | 0.008 | 0.15 | Leukotriene B4 antagonist | 0.15 0.005 CID_10688629 0.138 0.006 CID_18986923 0.141 0.005 CID_71374942 0.066 0.022 CID_10710332 | CID_10688629 | |
| 0.106 | 0.003 | 0.182 | Melatonin receptor 1A agonist | 0.04 0.013 CID_10688629 0.056 0.006 CID_18986923 0.055 0.006 CID_71374942 0.182 0.002 CID_10710332 | CID_10710332 | |
| 0.113 | 0.011 | 0.113 | Potassium channel (ATP-sensitive) blocker | 0.094 0.018 CID_10688629 0.102 0.015 CID_18986923 0.104 0.014 CID_71374942 0.094 0.018 CID_10710332 | ||
| 0.104 | 0.005 | 0.123 | Vanilloid 2 antagonist | 0.123 0.004 CID_10688629 0.107 0.005 CID_18986923 0.104 0.005 CID_71374942 0.086 0.008 CID_10710332 | CID_10688629 | |
| 0.187 | 0.09 | 0.259 | Neurotrophic factor enhancer | 0.259 0.034 CID_10688629 0.228 0.052 CID_18986923 0.23 0.052 CID_71374942 0.175 0.104 CID_10710332 | CID_10688629 | |
| 0.15 | 0.053 | 0.201 | Toll-Like receptor 2 antagonist | 0.19 0.028 CID_10688629 0.195 0.026 CID_18986923 0.194 0.026 CID_71374942 0.201 0.023 CID_10710332 | CID_10710332 | |
| 0.115 | 0.021 | 0.15 | Vanilloid agonist | 0.15 0.01 CID_10688629 0.129 0.015 CID_18986923 0.126 0.016 CID_71374942 0.105 0.028 CID_10710332 | CID_10688629 | |
| 0.123 | 0.028 | 0.136 | Lanosterol 14 alpha demethylase inhibitor | 0.136 0.018 CID_10688629 0.123 0.028 CID_18986923 0.122 0.029 CID_71374942 | CID_10688629 | |
| 0.128 | 0.034 | 0.128 | 5 Hydroxytryptamine 2A antagonist | 0.069 0.068 CID_18986923 0.072 0.065 CID_71374942 0.086 0.055 CID_10710332 | ||
| 0.205 | 0.112 | 0.218 | DNA damaging | 0.216 0.103 CID_10688629 0.218 0.102 CID_18986923 0.217 0.102 CID_71374942 0.207 0.11 CID_10710332 | CID_18986923 | |
| 0.121 | 0.029 | 0.139 | Histamine N-methyltransferase inhibitor | 0.139 0.019 CID_10688629 0.116 0.033 CID_18986923 0.118 0.031 CID_71374942 | CID_10688629 | |
| 0.113 | 0.021 | 0.113 | Acetylcholine M4 receptor antagonist | 0.081 0.045 CID_10688629 0.077 0.049 CID_18986923 0.077 0.049 CID_71374942 0.074 0.053 CID_10710332 | ||
| 0.144 | 0.052 | 0.144 | 5 Hydroxytryptamine antagonist | 0.101 0.078 CID_10710332 | ||
| 0.121 | 0.03 | 0.128 | ABCA1 expression enhancer | 0.128 0.026 CID_10688629 0.12 0.031 CID_18986923 0.118 0.032 CID_71374942 0.085 0.076 CID_10710332 | CID_10688629 | |
| 0.11 | 0.019 | 0.116 | Amidase inhibitor | 0.116 0.017 CID_10688629 0.095 0.027 CID_18986923 0.098 0.026 CID_71374942 0.114 0.018 CID_10710332 | CID_10688629 | |
| 0.168 | 0.079 | 0.168 | Tumour necrosis factor antagonist | 0.15 0.1 CID_18986923 0.146 0.106 CID_71374942 | ||
| 0.098 | 0.009 | 0.098 | Potassium channel Kv1.3 blocker | 0.063 0.019 CID_10688629 0.092 0.009 CID_18986923 0.097 0.009 CID_71374942 0.098 0.009 CID_10710332 | ||
| 0.132 | 0.044 | 0.142 | Photosensitizer | 0.123 0.053 CID_10688629 0.142 0.036 CID_18986923 0.141 0.037 CID_71374942 0.115 0.064 CID_10710332 | CID_18986923 | |
| 0.129 | 0.042 | 0.129 | Nav1.1 sodium channel blocker | 0.125 0.045 CID_10688629 0.125 0.045 CID_18986923 0.128 0.043 CID_71374942 | ||
| 0.127 | 0.041 | 0.127 | Multidrug resistance-associated protein 1 inhibitor | 0.116 0.053 CID_10688629 0.124 0.044 CID_18986923 0.124 0.044 CID_71374942 0.103 0.073 CID_10710332 | ||
| 0.105 | 0.02 | 0.13 | Leukotriene antagonist | 0.13 0.013 CID_10688629 0.117 0.016 CID_18986923 0.12 0.015 CID_71374942 0.077 0.034 CID_10710332 | CID_10688629 | |
| 0.123 | 0.038 | 0.151 | Breast cancer-resistant protein inhibitor | 0.089 0.067 CID_10688629 0.126 0.035 CID_18986923 0.126 0.035 CID_71374942 0.151 0.023 CID_10710332 | CID_10710332 | |
| 0.14 | 0.056 | 0.19 | Sphingosine 1-phosphate receptor 2 antagonist | 0.158 0.032 CID_10688629 0.139 0.057 CID_18986923 0.136 0.063 CID_71374942 0.19 0.01 CID_10710332 | CID_10710332 | |
| 0.125 | 0.043 | 0.246 | Carbonic anhydrase XV inhibitor | 0.157 0.028 CID_10688629 0.163 0.026 CID_18986923 0.158 0.028 CID_71374942 0.246 0.012 CID_10710332 | CID_10710332 | |
| 0.176 | 0.096 | 0.215 | DNA methylase inhibitor | 0.194 0.083 CID_10688629 0.215 0.07 CID_18986923 0.211 0.072 CID_71374942 0.184 0.09 CID_10710332 | CID_18986923 | |
| 0.097 | 0.018 | 0.097 | Acetylcholine M5 receptor antagonist | 0.096 0.019 CID_10688629 0.079 0.025 CID_18986923 0.08 0.024 CID_71374942 0.091 0.02 CID_10710332 | ||
| 0.11 | 0.033 | 0.169 | Carbonic anhydrase XIII inhibitor | 0.147 0.022 CID_10688629 0.169 0.018 CID_18986923 0.16 0.02 CID_71374942 0.127 0.027 CID_10710332 | CID_18986923 | |
| 0.082 | 0.005 | 0.091 | Dopamine autoreceptor agonist | 0.076 0.005 CID_10688629 0.087 0.004 CID_18986923 0.091 0.004 CID_71374942 0.053 0.007 CID_10710332 | CID_71374942 | |
| 0.115 | 0.039 | 0.12 | Alpha 1 adrenoreceptor antagonist | 0.069 0.06 CID_18986923 0.074 0.057 CID_71374942 0.12 0.037 CID_10710332 | CID_10710332 | |
| 0.175 | 0.1 | 0.214 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.213 0.062 CID_10688629 0.212 0.063 CID_18986923 0.214 0.062 CID_71374942 0.154 0.141 CID_10710332 | CID_71374942 | |
| 0.083 | 0.008 | 0.121 | Beta 2 adrenoreceptor agonist | 0.121 0.004 CID_10688629 0.102 0.004 CID_18986923 0.102 0.004 CID_71374942 0.111 0.004 CID_10710332 | CID_10688629 | |
| 0.108 | 0.033 | 0.108 | Alpha 2a adrenoreceptor antagonist | 0.1 0.036 CID_10688629 0.09 0.041 CID_18986923 0.094 0.039 CID_71374942 0.08 0.049 CID_10710332 | ||
| 0.094 | 0.019 | 0.094 | Peroxisome proliferator-activated receptor gamma antagonist | 0.093 0.02 CID_10688629 0.089 0.024 CID_18986923 0.089 0.023 CID_71374942 0.081 0.032 CID_10710332 | ||
| 0.1 | 0.025 | 0.131 | Sphingosine 1-phosphate receptor 4 agonist | 0.108 0.021 CID_10688629 0.084 0.034 CID_18986923 0.083 0.034 CID_71374942 0.131 0.013 CID_10710332 | CID_10710332 | |
| 0.084 | 0.011 | 0.084 | 5 Hydroxytryptamine 1B agonist | 0.077 0.013 CID_10688629 0.066 0.021 CID_18986923 0.066 0.021 CID_71374942 0.063 0.023 CID_10710332 | ||
| 0.097 | 0.024 | 0.097 | 5 Hydroxytryptamine 1D antagonist | 0.055 0.054 CID_18986923 | ||
| 0.155 | 0.083 | 0.187 | Arachidonic acid antagonist | 0.187 0.046 CID_10688629 0.166 0.07 CID_18986923 0.161 0.076 CID_71374942 0.125 0.119 CID_10710332 | CID_10688629 | |
| 0.123 | 0.051 | 0.265 | Chelator | 0.265 0.014 CID_10688629 0.196 0.025 CID_18986923 0.19 0.026 CID_71374942 0.112 0.062 CID_10710332 | CID_10688629 | |
| 0.08 | 0.01 | 0.112 | Squalene epoxidase inhibitor | 0.112 0.004 CID_10688629 0.078 0.01 CID_18986923 0.079 0.01 CID_71374942 0.058 0.022 CID_10710332 | CID_10688629 | |
| 0.075 | 0.005 | 0.199 | Melatonin agonist | 0.037 0.018 CID_10688629 0.047 0.01 CID_18986923 0.046 0.011 CID_71374942 0.199 0.004 CID_10710332 | CID_10710332 | |
| 0.113 | 0.043 | 0.158 | Nitric-oxide synthase inhibitor | 0.111 0.045 CID_10688629 0.092 0.074 CID_18986923 0.09 0.078 CID_71374942 0.158 0.019 CID_10710332 | CID_10710332 | |
| 0.114 | 0.046 | 0.114 | Antihistaminic | 0.09 0.064 CID_10688629 0.084 0.072 CID_10710332 | ||
| 0.1 | 0.032 | 0.115 | Glycine receptor antagonist | 0.115 0.021 CID_10688629 0.094 0.038 CID_18986923 0.094 0.038 CID_71374942 | CID_10688629 | |
| 0.161 | 0.094 | 0.207 | DNA methyltransferase I inhibitor | 0.177 0.082 CID_10688629 0.207 0.065 CID_18986923 0.202 0.068 CID_71374942 0.16 0.094 CID_10710332 | CID_18986923 | |
| 0.082 | 0.016 | 0.136 | Sphingosine 1-phosphate receptor 3 antagonist | 0.094 0.01 CID_10688629 0.081 0.017 CID_18986923 0.081 0.017 CID_71374942 0.136 0.004 CID_10710332 | CID_10710332 | |
| 0.101 | 0.035 | 0.101 | Alpha 1b adrenoreceptor antagonist | 0.071 0.052 CID_18986923 0.075 0.049 CID_71374942 0.092 0.038 CID_10710332 | ||
| 0.089 | 0.023 | 0.089 | 5 Hydroxytryptamine 1 agonist | 0.043 0.042 CID_10688629 0.054 0.035 CID_10710332 | ||
| 0.093 | 0.027 | 0.093 | 5 Hydroxytryptamine 1B antagonist | |||
| 0.077 | 0.014 | 0.082 | Epithelial sodium channel blocker | 0.074 0.015 CID_10688629 0.071 0.017 CID_18986923 0.069 0.019 CID_71374942 0.082 0.012 CID_10710332 | CID_10710332 | |
| 0.141 | 0.079 | 0.188 | Neuropeptide Y1 antagonist | 0.142 0.078 CID_18986923 0.144 0.075 CID_71374942 0.188 0.024 CID_10710332 | CID_10710332 | |
| 0.1 | 0.039 | 0.207 | Carbonic anhydrase VI inhibitor | 0.168 0.017 CID_10688629 0.155 0.02 CID_18986923 0.154 0.02 CID_71374942 0.207 0.012 CID_10710332 | CID_10710332 | |
| 0.173 | 0.112 | 0.173 | Potassium channel blocker | |||
| 0.146 | 0.086 | 0.191 | Melanin inhibitor | 0.171 0.059 CID_10688629 0.191 0.045 CID_18986923 0.187 0.047 CID_71374942 0.165 0.064 CID_10710332 | CID_18986923 | |
| 0.072 | 0.013 | 0.079 | Lysophosphatidic acid 3 receptor antagonist | 0.068 0.015 CID_10688629 0.063 0.02 CID_18986923 0.062 0.021 CID_71374942 0.079 0.01 CID_10710332 | CID_10710332 | |
| 0.067 | 0.008 | 0.067 | Benzodiazepine antagonist | 0.044 0.042 CID_10688629 0.046 0.035 CID_18986923 0.048 0.032 CID_71374942 | ||
| 0.123 | 0.065 | 0.123 | Beta amyloid protein antagonist | 0.113 0.075 CID_18986923 0.102 0.087 CID_71374942 0.109 0.078 CID_10710332 | ||
| 0.103 | 0.046 | 0.103 | Histamine antagonist | 0.076 0.068 CID_10688629 0.073 0.072 CID_10710332 | ||
| 0.087 | 0.03 | 0.14 | Dopamine D1 antagonist | 0.14 0.016 CID_10688629 0.128 0.018 CID_18986923 0.133 0.017 CID_71374942 | CID_10688629 | |
| 0.086 | 0.03 | 0.086 | Dopamine D3 antagonist | 0.061 0.044 CID_10688629 0.064 0.041 CID_18986923 0.067 0.039 CID_71374942 0.063 0.042 CID_10710332 | ||
| 0.234 | 0.179 | 0.355 | 15-Lipoxygenase inhibitor | 0.355 0.096 CID_10688629 0.333 0.11 CID_18986923 0.338 0.107 CID_71374942 0.256 0.16 CID_10710332 | CID_10688629 | |
| 0.191 | 0.136 | 0.192 | Neuropeptide Y2 antagonist | 0.189 0.14 CID_10688629 0.189 0.141 CID_18986923 0.192 0.134 CID_71374942 0.182 0.155 CID_10710332 | CID_71374942 | |
| 0.06 | 0.007 | 0.114 | Melatonin 1 agonist | 0.034 0.022 CID_10688629 0.044 0.012 CID_18986923 0.043 0.013 CID_71374942 0.114 0.004 CID_10710332 | CID_10710332 | |
| 0.176 | 0.123 | 0.182 | ErbB-1 antagonist | 0.18 0.116 CID_18986923 0.182 0.112 CID_71374942 0.172 0.13 CID_10710332 | CID_71374942 | |
| 0.062 | 0.011 | 0.071 | Neuraminidase (Influenza A) inhibitor | 0.071 0.007 CID_10688629 0.065 0.01 CID_18986923 0.063 0.01 CID_71374942 0.043 0.037 CID_10710332 | CID_10688629 | |
| 0.064 | 0.013 | 0.064 | Dopamine D3 agonist | 0.061 0.014 CID_10688629 0.059 0.014 CID_18986923 0.059 0.015 CID_71374942 0.064 0.013 CID_10710332 | ||
| 0.153 | 0.101 | 0.209 | Phospholipase C inhibitor | 0.209 0.038 CID_10688629 0.181 0.059 CID_18986923 0.182 0.059 CID_71374942 0.165 0.08 CID_10710332 | CID_10688629 | |
| 0.126 | 0.075 | 0.167 | NADPH oxidase inhibitor | 0.153 0.052 CID_10688629 0.16 0.049 CID_18986923 0.167 0.045 CID_71374942 0.105 0.104 CID_10710332 | CID_71374942 | |
| 0.089 | 0.039 | 0.096 | Interferon agonist | 0.096 0.033 CID_10688629 0.087 0.042 CID_18986923 0.086 0.044 CID_71374942 0.082 0.049 CID_10710332 | CID_10688629 | |
| 0.182 | 0.132 | 0.268 | Immunostimulant | 0.268 0.089 CID_10688629 0.242 0.099 CID_18986923 0.234 0.103 CID_71374942 0.195 0.123 CID_10710332 | CID_10688629 | |
| 0.1 | 0.05 | 0.105 | Toll-Like receptor 3 antagonist | 0.105 0.044 CID_10710332 | CID_10710332 | |
| 0.128 | 0.078 | 0.157 | Bone formation stimulant | 0.15 0.059 CID_10688629 0.157 0.053 CID_18986923 0.155 0.055 CID_71374942 0.111 0.094 CID_10710332 | CID_18986923 | |
| 0.057 | 0.01 | 0.057 | 5 Hydroxytryptamine 2B agonist | 0.038 0.028 CID_18986923 0.039 0.028 CID_71374942 0.041 0.024 CID_10710332 | ||
| 0.068 | 0.021 | 0.068 | 5 Hydroxytryptamine 7 agonist | 0.06 0.032 CID_18986923 0.061 0.03 CID_71374942 0.056 0.039 CID_10710332 | ||
| 0.056 | 0.01 | 0.092 | Beta adrenoreceptor agonist | 0.092 0.004 CID_10688629 0.076 0.005 CID_18986923 0.076 0.005 CID_71374942 0.089 0.004 CID_10710332 | CID_10688629 | |
| 0.18 | 0.135 | 0.241 | Calpain inhibitor | 0.175 0.141 CID_10688629 0.241 0.073 CID_10710332 | CID_10710332 | |
| 0.08 | 0.036 | 0.145 | Carbonic anhydrase VA inhibitor | 0.104 0.023 CID_10688629 0.095 0.028 CID_18986923 0.094 0.028 CID_71374942 0.145 0.012 CID_10710332 | CID_10710332 | |
| 0.109 | 0.066 | 0.149 | Mucolytic | 0.123 0.051 CID_10688629 0.129 0.046 CID_18986923 0.127 0.048 CID_71374942 0.149 0.033 CID_10710332 | CID_10710332 | |
| 0.248 | 0.207 | 0.364 | Calcium channel L-type activator | 0.292 0.164 CID_10688629 0.349 0.118 CID_18986923 0.364 0.107 CID_71374942 0.313 0.146 CID_10710332 | CID_71374942 | |
| 0.074 | 0.034 | 0.074 | Acetylcholine M2 receptor antagonist | 0.064 0.041 CID_10688629 0.07 0.037 CID_18986923 0.07 0.036 CID_71374942 0.059 0.046 CID_10710332 | ||
| 0.048 | 0.008 | 0.048 | Benzodiazepine receptor peripheral-type antagonist | 0.038 0.017 CID_10688629 0.038 0.016 CID_18986923 0.039 0.015 CID_71374942 | ||
| 0.055 | 0.018 | 0.061 | Leukotriene A4 hydrolase inhibitor | 0.061 0.015 CID_10688629 0.037 0.027 CID_18986923 0.038 0.027 CID_71374942 0.051 0.02 CID_10710332 | CID_10688629 | |
| 0.045 | 0.009 | 0.118 | Melatonin antagonist | 0.028 0.02 CID_18986923 0.028 0.02 CID_71374942 0.118 0.004 CID_10710332 | CID_10710332 | |
| 0.066 | 0.03 | 0.121 | Carbonic anhydrase VB inhibitor | 0.11 0.014 CID_10688629 0.081 0.022 CID_18986923 0.08 0.022 CID_71374942 0.121 0.012 CID_10710332 | CID_10710332 | |
| 0.043 | 0.007 | 0.043 | Thiazolidinedione | 0.039 0.009 CID_10688629 0.039 0.009 CID_18986923 0.039 0.009 CID_71374942 0.042 0.008 CID_10710332 | ||
| 0.048 | 0.013 | 0.048 | Peroxisome proliferator-activated receptor delta agonist | 0.04 0.017 CID_10688629 0.038 0.018 CID_18986923 0.037 0.02 CID_71374942 0.033 0.024 CID_10710332 | ||
| 0.046 | 0.012 | 0.116 | Melatonin 2 agonist | 0.038 0.017 CID_18986923 0.037 0.018 CID_71374942 0.116 0.004 CID_10710332 | CID_10710332 | |
| 0.074 | 0.04 | 0.158 | Carbonic anhydrase V inhibitor | 0.111 0.024 CID_10688629 0.093 0.029 CID_18986923 0.093 0.03 CID_71374942 0.158 0.013 CID_10710332 | CID_10710332 | |
| 0.053 | 0.019 | 0.064 | Geranyltranstransferase inhibitor | 0.064 0.011 CID_10688629 0.052 0.021 CID_18986923 0.051 0.022 CID_71374942 0.051 0.022 CID_10710332 | CID_10688629 | |
| 0.063 | 0.029 | 0.066 | Ryanodine receptor antagonist | 0.066 0.024 CID_18986923 0.064 0.027 CID_71374942 0.06 0.037 CID_10710332 | CID_18986923 | |
| 0.038 | 0.005 | 0.038 | Lysophosphatidic acid 1 receptor antagonist | 0.026 0.009 CID_10688629 0.026 0.008 CID_18986923 0.027 0.008 CID_71374942 0.023 0.012 CID_10710332 | ||
| 0.059 | 0.026 | 0.118 | Carbonic anhydrase XIV inhibitor | 0.077 0.018 CID_10688629 0.088 0.014 CID_18986923 0.085 0.015 CID_71374942 0.118 0.007 CID_10710332 | CID_10710332 | |
| 0.118 | 0.085 | 0.142 | Antibacterial (Helicobacter pylori) | 0.118 0.084 CID_10688629 0.114 0.091 CID_18986923 0.114 0.091 CID_71374942 0.142 0.053 CID_10710332 | CID_10710332 | |
| 0.068 | 0.036 | 0.07 | Alpha 1d adrenoreceptor antagonist | 0.07 0.035 CID_10710332 | CID_10710332 | |
| 0.069 | 0.037 | 0.069 | Dopamine D4 antagonist | 0.05 0.049 CID_71374942 0.061 0.042 CID_10710332 | ||
| 0.054 | 0.022 | 0.079 | Adenylate cyclase 1 inhibitor | 0.058 0.019 CID_10688629 0.053 0.024 CID_18986923 0.051 0.026 CID_71374942 0.079 0.008 CID_10710332 | CID_10710332 | |
| 0.035 | 0.003 | 0.112 | Estrogen-related receptor gamma agonist | 0.112 0.002 CID_10688629 0.06 0.002 CID_18986923 0.061 0.002 CID_71374942 0.03 0.004 CID_10710332 | CID_10688629 | |
| 0.059 | 0.028 | 0.059 | 5 Hydroxytryptamine 2 agonist | 0.049 0.039 CID_10710332 | ||
| 0.068 | 0.037 | 0.075 | Interferon inducer | 0.075 0.029 CID_10688629 0.067 0.04 CID_18986923 0.066 0.041 CID_71374942 0.065 0.044 CID_10710332 | CID_10688629 | |
| 0.045 | 0.015 | 0.054 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | 0.054 0.009 CID_10688629 0.038 0.024 CID_18986923 0.035 0.028 CID_71374942 | CID_10688629 | |
| 0.084 | 0.054 | 0.084 | Histamine H1 receptor antagonist | 0.072 0.066 CID_10688629 | ||
| 0.043 | 0.014 | 0.043 | Free fatty acid receptor 1 antagonist | 0.039 0.017 CID_10688629 0.031 0.028 CID_71374942 0.032 0.026 CID_10710332 | ||
| 0.036 | 0.008 | 0.048 | Estrogen-related receptor gamma antagonist | 0.048 0.004 CID_10688629 0.044 0.004 CID_18986923 0.045 0.004 CID_71374942 | CID_10688629 | |
| 0.072 | 0.045 | 0.072 | 5 Hydroxytryptamine agonist | |||
| 0.031 | 0.004 | 0.113 | Melatonin receptor 1A antagonist | 0.113 0.003 CID_10710332 | CID_10710332 | |
| 0.036 | 0.01 | 0.041 | Peroxisome proliferator-activated receptor alpha antagonist | 0.041 0.009 CID_10688629 0.028 0.012 CID_18986923 0.028 0.012 CID_71374942 | CID_10688629 | |
| 0.08 | 0.054 | 0.08 | Acetylcholine nicotinic antagonist | |||
| 0.075 | 0.05 | 0.075 | Phosphodiesterase VI inhibitor | 0.071 0.058 CID_18986923 0.071 0.06 CID_71374942 0.075 0.051 CID_10710332 | ||
| 0.037 | 0.013 | 0.046 | Leukotriene B4 receptor 1 antagonist | 0.046 0.009 CID_10688629 0.039 0.012 CID_18986923 0.038 0.013 CID_71374942 | CID_10688629 | |
| 0.097 | 0.073 | 0.134 | Falcipain 3 inhibitor | 0.087 0.085 CID_10688629 0.134 0.045 CID_10710332 | CID_10710332 | |
| 0.032 | 0.008 | 0.04 | Leukotriene B4 receptor 2 antagonist | 0.04 0.005 CID_10688629 0.033 0.007 CID_18986923 0.032 0.008 CID_71374942 | CID_10688629 | |
| 0.043 | 0.02 | 0.056 | Diamine oxidase inhibitor | 0.056 0.011 CID_10710332 | CID_10710332 | |
| 0.029 | 0.007 | 0.05 | Glutaminyl-peptide cyclotransferase inhibitor | 0.05 0.004 CID_10710332 | CID_10710332 | |
| 0.048 | 0.027 | 0.064 | Sphingosine 1-phosphate receptor agonist | 0.047 0.027 CID_10688629 0.04 0.038 CID_18986923 0.064 0.014 CID_10710332 | CID_10710332 | |
| 0.096 | 0.075 | 0.12 | Mediator release inhibitor | 0.12 0.048 CID_10688629 0.113 0.054 CID_18986923 0.114 0.053 CID_71374942 | CID_10688629 | |
| 0.071 | 0.05 | 0.079 | Alpha 1a adrenoreceptor antagonist | 0.079 0.046 CID_10710332 | CID_10710332 | |
| 0.111 | 0.09 | 0.123 | Tubulin antagonist | 0.123 0.077 CID_18986923 0.121 0.079 CID_71374942 0.114 0.086 CID_10710332 | CID_18986923 | |
| 0.045 | 0.025 | 0.056 | Sphingosine 1-phosphate receptor 1 agonist | 0.048 0.021 CID_10688629 0.038 0.035 CID_18986923 0.056 0.015 CID_10710332 | CID_10710332 | |
| 0.076 | 0.056 | 0.121 | Estrogen receptor alpha antagonist | 0.121 0.018 CID_10688629 0.112 0.021 CID_18986923 0.11 0.022 CID_71374942 | CID_10688629 | |
| 0.027 | 0.008 | 0.081 | Melatonin 1 antagonist | 0.081 0.004 CID_10710332 | CID_10710332 | |
| 0.043 | 0.024 | 0.112 | Dopamine D5 agonist | 0.112 0.004 CID_10688629 0.066 0.01 CID_18986923 0.067 0.009 CID_71374942 0.044 0.023 CID_10710332 | CID_10688629 | |
| 0.035 | 0.016 | 0.035 | 5 Hydroxytryptamine 1D agonist | |||
| 0.101 | 0.083 | 0.132 | Nav1.5 sodium channel blocker | 0.132 0.041 CID_10710332 | CID_10710332 | |
| 0.054 | 0.036 | 0.072 | Alpha tubulin antagonist | 0.062 0.029 CID_10688629 0.072 0.023 CID_18986923 0.07 0.024 CID_71374942 0.06 0.03 CID_10710332 | CID_18986923 | |
| 0.039 | 0.022 | 0.057 | Kainate receptor 2 antagonist | 0.057 0.013 CID_10688629 0.031 0.029 CID_18986923 | CID_10688629 | |
| 0.043 | 0.026 | 0.056 | Liver X receptor alpha agonist | 0.056 0.015 CID_10688629 0.049 0.02 CID_18986923 0.051 0.019 CID_71374942 | CID_10688629 | |
| 0.061 | 0.044 | 0.061 | 5 Hydroxytryptamine 7 antagonist | |||
| 0.094 | 0.078 | 0.137 | AMP-activated protein kinase stimulant | 0.137 0.037 CID_10688629 0.124 0.046 CID_18986923 0.119 0.05 CID_71374942 0.125 0.045 CID_10710332 | CID_10688629 | |
| 0.137 | 0.121 | 0.17 | Platelet adhesion inhibitor | 0.165 0.091 CID_10688629 0.157 0.098 CID_18986923 0.156 0.099 CID_71374942 0.17 0.088 CID_10710332 | CID_10710332 | |
| 0.019 | 0.004 | 0.037 | Melatonin 2 antagonist | 0.037 0.003 CID_10710332 | CID_10710332 | |
| 0.05 | 0.035 | 0.05 | Potassium channel (Inward rectifier) blocker | |||
| 0.14 | 0.125 | 0.205 | Interleukin antagonist | 0.194 0.087 CID_10688629 0.205 0.081 CID_18986923 0.204 0.082 CID_71374942 | CID_18986923 | |
| 0.094 | 0.081 | 0.176 | Monophenol monooxygenase inhibitor | 0.165 0.042 CID_10688629 0.176 0.039 CID_18986923 0.171 0.04 CID_71374942 0.114 0.066 CID_10710332 | CID_18986923 | |
| 0.077 | 0.064 | 0.083 | Phosphodiesterase IV inhibitor | 0.083 0.058 CID_10710332 | CID_10710332 | |
| 0.092 | 0.079 | 0.126 | Expectorant | 0.105 0.063 CID_10688629 0.113 0.056 CID_18986923 0.111 0.058 CID_71374942 0.126 0.047 CID_10710332 | CID_10710332 | |
| 0.078 | 0.066 | 0.141 | Inducible nitric-oxide synthase inhibitor | 0.077 0.068 CID_10688629 0.141 0.018 CID_10710332 | CID_10710332 | |
| 0.054 | 0.042 | 0.06 | Potassium channel Kv1.5 blocker | 0.06 0.036 CID_10710332 | CID_10710332 | |
| 0.08 | 0.068 | 0.106 | Ornithine decarboxylase inhibitor | 0.105 0.039 CID_10688629 0.093 0.052 CID_18986923 0.089 0.057 CID_71374942 0.106 0.038 CID_10710332 | CID_10710332 | |
| 0.035 | 0.024 | 0.043 | Phosphoglycerate kinase inhibitor | 0.041 0.019 CID_10688629 0.043 0.018 CID_18986923 0.04 0.019 CID_71374942 | CID_18986923 | |
| 0.034 | 0.022 | 0.034 | Peroxisome proliferator-activated receptor delta antagonist | 0.034 0.021 CID_10688629 0.032 0.027 CID_18986923 0.031 0.027 CID_71374942 | ||
| 0.13 | 0.119 | 0.141 | Ca2+-transporting ATPase inhibitor | 0.141 0.068 CID_10688629 0.134 0.097 CID_18986923 0.133 0.105 CID_71374942 | CID_10688629 | |
| 0.046 | 0.036 | 0.054 | Cholesterol esterase inhibitor | 0.054 0.025 CID_10688629 | CID_10688629 | |
| 0.129 | 0.12 | 0.171 | Nitric oxide antagonist | 0.171 0.081 CID_10688629 0.171 0.081 CID_18986923 0.166 0.084 CID_71374942 | CID_18986923 | |
| 0.03 | 0.021 | 0.038 | Lysophosphatidic acid 2 receptor antagonist | 0.033 0.017 CID_10688629 0.038 0.013 CID_10710332 | CID_10710332 | |
| 0.021 | 0.014 | 0.025 | Neuraminidase (Influenza B) inhibitor | 0.025 0.008 CID_10688629 0.024 0.01 CID_18986923 0.022 0.012 CID_71374942 | CID_10688629 | |
| 0.047 | 0.04 | 0.053 | Prolyl endopeptidase inhibitor | 0.053 0.032 CID_10688629 | CID_10688629 | |
| 0.03 | 0.024 | 0.03 | Cholesterol ester transfer protein antagonist | |||
| 0.052 | 0.047 | 0.052 | Dopamine uptake inhibitor | |||
| 0.054 | 0.049 | 0.063 | Leukotriene C antagonist | 0.063 0.024 CID_10688629 0.054 0.046 CID_18986923 0.055 0.044 CID_71374942 | CID_10688629 | |
| 0.087 | 0.083 | 0.102 | Bile acid receptor antagonist | 0.102 0.045 CID_10688629 0.1 0.05 CID_18986923 0.099 0.051 CID_71374942 | CID_10688629 | |
| 0.055 | 0.051 | 0.057 | Gonadotropin-releasing hormone receptor agonist | 0.057 0.046 CID_18986923 0.057 0.046 CID_71374942 | CID_71374942 | |
| 0.025 | 0.021 | 0.025 | Urotensin II agonist | 0.025 0.021 CID_18986923 0.025 0.021 CID_71374942 | ||
| 0.021 | 0.018 | 0.021 | Corticotropin releasing factor 1 receptor antagonist | |||
| 0.109 | 0.106 | 0.109 | Interleukin 1 antagonist | |||
| 0.014 | 0.012 | 0.017 | NMDA receptor phencyclidine site antagonist | 0.015 0.01 CID_18986923 0.017 0.009 CID_71374942 | CID_71374942 | |
| 0.08 | 0.078 | 0.085 | ATPase (Vacuolar H+) inhibitor | 0.084 0.068 CID_10688629 0.084 0.068 CID_18986923 0.085 0.068 CID_71374942 | CID_71374942 | |
| 0.052 | 0.051 | 0.052 | Acetyl-CoA transferase 2 inhibitor | 0.052 0.051 CID_10688629 | ||
| 0.057 | 0.056 | 0.057 | Fibroblast growth factor 2 antagonist | |||
| 0.134 | 0.132 | 0.15 | Lipocortins synthesis antagonist | 0.15 0.105 CID_10688629 0.141 0.119 CID_18986923 0.139 0.123 CID_71374942 | CID_10688629 | |
| 0.108 | 0.106 | 0.108 | Toll-Like receptor antagonist | 0.108 0.107 CID_10688629 | ||
| 0.045 | 0.044 | 0.045 | H+/K+-transporting ATPase inhibitor | |||
| 0.04 | 0.039 | 0.065 | Glycine transporter 2 inhibitor | 0.042 0.037 CID_10688629 0.054 0.028 CID_18986923 0.056 0.027 CID_71374942 0.065 0.023 CID_10710332 | CID_10710332 | |
| 0.089 | 0.088 | 0.116 | Glutamate (mGluR7) agonist | 0.116 0.035 CID_10710332 | CID_10710332 | |
| 0.025 | 0.024 | 0.032 | Myristoyl transferase inhibitor | 0.032 0.011 CID_10710332 | CID_10710332 | |
| 0.084 | 0.084 | 0.102 | Interleukin 1 beta converting enzyme inhibitor | 0.092 0.068 CID_10688629 0.086 0.078 CID_18986923 0.087 0.076 CID_71374942 0.102 0.055 CID_10710332 | CID_10710332 | |
| 0.08 | 0.081 | 0.159 | 5-Lipoxygenase inhibitor | 0.159 0.034 CID_10688629 0.129 0.046 CID_18986923 0.128 0.046 CID_71374942 | CID_10688629 | |
| 0.122 | 0.123 | 0.129 | Pregnane X receptor agonist | 0.129 0.103 CID_10688629 | CID_10688629 | |
| 0.121 | 0.123 | 0.137 | GABA C receptor rho-2 antagonist | 0.125 0.116 CID_71374942 0.137 0.093 CID_10710332 | CID_10710332 | |
| 0.083 | 0.087 | 0.133 | Carbonic anhydrase III inhibitor | 0.133 0.036 CID_10688629 0.12 0.044 CID_18986923 0.121 0.043 CID_71374942 0.102 0.06 CID_10710332 | CID_10688629 | |
| 0.019 | 0.023 | 0.038 | Beta 1 adrenoreceptor agonist | 0.031 0.007 CID_10688629 0.026 0.011 CID_18986923 0.026 0.011 CID_71374942 0.038 0.005 CID_10710332 | CID_10710332 | |
| 0.125 | 0.13 | 0.149 | CF transmembrane conductance regulator agonist | 0.149 0.078 CID_18986923 0.147 0.082 CID_71374942 | CID_18986923 | |
| 0.06 | 0.065 | 0.067 | Catalase inhibitor | 0.064 0.06 CID_10688629 0.064 0.061 CID_18986923 0.067 0.058 CID_10710332 | CID_10710332 | |
| 0.02 | 0.025 | 0.022 | Isoleucine-tRNA ligase inhibitor | 0.022 0.016 CID_10688629 | CID_10688629 | |
| 0.04 | 0.046 | 0.054 | Metalloproteinase-3 inhibitor | 0.054 0.028 CID_10710332 | CID_10710332 | |
| 0.036 | 0.042 | 0.046 | 5 Hydroxytryptamine 1A agonist | 0.046 0.031 CID_10710332 | CID_10710332 | |
| 0.038 | 0.045 | 0.045 | Dihydrofolate reductase inhibitor | 0.045 0.026 CID_10710332 | CID_10710332 | |
| 0.113 | 0.12 | 0.146 | Farnesoid X receptor antagonist | 0.143 0.06 CID_10688629 0.146 0.057 CID_18986923 0.144 0.059 CID_71374942 | CID_18986923 | |
| 0.025 | 0.033 | 0.06 | Gonadotropin-releasing hormone receptor antagonist | 0.06 0.014 CID_10710332 | CID_10710332 | |
| 0.037 | 0.045 | 0.069 | Carbonic anhydrase VII inhibitor | 0.05 0.028 CID_10688629 0.049 0.029 CID_18986923 0.048 0.03 CID_71374942 0.069 0.015 CID_10710332 | CID_10710332 | |
| 0.027 | 0.036 | 0.035 | Retinoid X alpha receptor agonist | 0.035 0.024 CID_10688629 | CID_10688629 | |
| 0.021 | 0.03 | 0.029 | Vanilloid 2 agonist | 0.029 0.011 CID_10688629 0.023 0.022 CID_18986923 | CID_10688629 | |
| 0.056 | 0.065 | 0.079 | Neuraminidase (influenza) inhibitor | 0.079 0.026 CID_10688629 0.07 0.035 CID_18986923 0.067 0.039 CID_71374942 | CID_10688629 | |
| 0.011 | 0.021 | 0.019 | Thyroid hormone alpha antagonist | 0.019 0.008 CID_10688629 0.014 0.013 CID_18986923 | CID_10688629 | |
| 0.055 | 0.065 | 0.183 | Phenylalanine 4-hydroxylase inhibitor | 0.183 0.008 CID_10688629 0.086 0.033 CID_18986923 0.087 0.032 CID_71374942 | CID_10688629 | |
| 0.012 | 0.022 | 0.015 | Adenosine A2 receptor agonist | 0.015 0.013 CID_10688629 | CID_10688629 | |
| 0.054 | 0.064 | 0.064 | Bcl-xL inhibitor | 0.064 0.03 CID_10688629 | CID_10688629 | |
| 0.121 | 0.132 | 0.143 | Interferon gamma antagonist | 0.143 0.088 CID_10688629 0.143 0.088 CID_18986923 0.139 0.093 CID_71374942 | CID_18986923 | |
| 0.022 | 0.032 | 0.029 | Acid ceramidase inhibitor | 0.029 0.01 CID_10710332 | CID_10710332 | |
| 0.034 | 0.048 | 0.04 | Leukotriene C4 antagonist | 0.04 0.024 CID_10688629 | CID_10688629 | |
| 0.067 | 0.081 | 0.081 | GABA B receptor agonist | 0.081 0.04 CID_10688629 0.08 0.043 CID_18986923 0.079 0.044 CID_71374942 | CID_10688629 | |
| 0.034 | 0.048 | 0.044 | Oleamide hydrolase inhibitor | 0.044 0.033 CID_10710332 | CID_10710332 | |
| 0.168 | 0.182 | 0.192 | Transcription factor STAT3 inhibitor | 0.19 0.148 CID_10688629 0.178 0.168 CID_18986923 0.177 0.169 CID_71374942 0.192 0.146 CID_10710332 | CID_10710332 | |
| 0.041 | 0.056 | 0.063 | Beta tubulin antagonist | 0.063 0.038 CID_18986923 0.062 0.039 CID_71374942 0.055 0.043 CID_10710332 | CID_18986923 | |
| 0.045 | 0.06 | 0.074 | Sphingosine kinase 2 inhibitor | 0.074 0.019 CID_10688629 0.052 0.044 CID_18986923 0.05 0.047 CID_71374942 0.056 0.036 CID_10710332 | CID_10688629 | |
| 0.057 | 0.073 | 0.095 | Histone deacetylase SIRT2 inhibitor | 0.095 0.033 CID_10710332 | CID_10710332 | |
| 0.03 | 0.046 | 0.049 | Oxytocin agonist | 0.049 0.025 CID_10688629 0.044 0.028 CID_18986923 0.041 0.031 CID_71374942 | CID_10688629 | |
| 0.043 | 0.061 | 0.05 | Alpha-mannosidase inhibitor | 0.05 0.044 CID_10688629 0.049 0.046 CID_18986923 | CID_10688629 | |
| 0.019 | 0.037 | 0.027 | Liver X receptor beta antagonist | 0.027 0.022 CID_10688629 | CID_10688629 | |
| 0.016 | 0.034 | 0.022 | Prostaglandin F2 alpha agonist | 0.022 0.017 CID_10688629 | CID_10688629 | |
| 0.084 | 0.102 | 0.172 | Adenylate cyclase inhibitor | 0.172 0.033 CID_10688629 0.114 0.073 CID_18986923 0.113 0.073 CID_71374942 0.093 0.091 CID_10710332 | CID_10688629 | |
| 0.094 | 0.113 | 0.147 | Estrogen antagonist | 0.133 0.035 CID_10688629 0.147 0.024 CID_18986923 0.144 0.026 CID_71374942 | CID_18986923 | |
| 0.122 | 0.141 | 0.208 | Angiogenesis stimulant | 0.208 0.091 CID_10688629 0.203 0.093 CID_18986923 0.196 0.096 CID_71374942 0.18 0.105 CID_10710332 | CID_10688629 | |
| 0.06 | 0.081 | 0.067 | Glycine receptor agonist | 0.067 0.062 CID_10688629 | CID_10688629 | |
| 0.096 | 0.118 | 0.108 | Sphingosine 1-phosphate receptor 2 agonist | 0.108 0.079 CID_10710332 | CID_10710332 | |
| 0.043 | 0.065 | 0.057 | Carbonic anhydrase inhibitor | 0.057 0.048 CID_10688629 | CID_10688629 | |
| 0.048 | 0.071 | 0.057 | Immunoglobulin Fc receptor antagonist | 0.057 0.033 CID_10710332 | CID_10710332 | |
| 0.031 | 0.054 | 0.05 | Carbonic anhydrase XII inhibitor | 0.05 0.038 CID_10688629 | CID_10688629 | |
| 0.077 | 0.101 | 0.123 | Xanthine oxidase inhibitor | 0.123 0.046 CID_10688629 0.116 0.05 CID_18986923 0.11 0.053 CID_71374942 | CID_10688629 | |
| 0.169 | 0.193 | 0.224 | Hypoxia-inducible factor 1 alpha inhibitor | 0.201 0.151 CID_10688629 0.222 0.127 CID_18986923 0.224 0.125 CID_71374942 | CID_71374942 | |
| 0.026 | 0.051 | 0.045 | Dopamine D5 antagonist | 0.045 0.029 CID_10688629 | CID_10688629 | |
| 0.056 | 0.081 | 0.095 | Topoisomerase II alpha inhibitor | 0.081 0.052 CID_10688629 0.095 0.043 CID_18986923 0.095 0.043 CID_71374942 0.081 0.052 CID_10710332 | CID_71374942 | |
| 0.061 | 0.086 | 0.104 | Macrophage migration inhibitory factor inhibitor | 0.09 0.041 CID_10688629 0.103 0.033 CID_18986923 0.104 0.033 CID_71374942 | CID_71374942 | |
| 0.086 | 0.112 | 0.166 | Amylase inhibitor | 0.155 0.062 CID_10688629 0.166 0.057 CID_18986923 0.163 0.058 CID_71374942 | CID_18986923 | |
| 0.038 | 0.064 | 0.075 | Maillard reaction inhibitor | 0.075 0.027 CID_10688629 0.056 0.038 CID_18986923 0.055 0.038 CID_71374942 0.049 0.045 CID_10710332 | CID_10688629 | |
| 0.044 | 0.07 | 0.051 | Sphingosine 1-phosphate receptor 5 agonist | 0.051 0.043 CID_10710332 | CID_10710332 | |
| 0.06 | 0.086 | 0.069 | Metalloproteinase-2 inhibitor | 0.069 0.067 CID_10710332 | CID_10710332 | |
| 0.065 | 0.091 | 0.082 | Sphingosine 1-phosphate receptor antagonist | 0.082 0.042 CID_10710332 | CID_10710332 | |
| 0.169 | 0.196 | 0.185 | Gastrin inhibitor | 0.185 0.172 CID_10710332 | CID_10710332 | |
| 0.045 | 0.073 | 0.057 | Sphingosine 1-phosphate receptor 1 antagonist | 0.057 0.035 CID_10710332 | CID_10710332 | |
| 0.049 | 0.076 | 0.075 | Alpha adrenoreceptor agonist | 0.075 0.041 CID_10710332 | CID_10710332 | |
| 0.083 | 0.111 | 0.149 | Histone deacetylase class III inhibitor | 0.106 0.083 CID_10688629 0.149 0.044 CID_10710332 | CID_10710332 | |
| 0.042 | 0.069 | 0.075 | Neuraminidase inhibitor | 0.075 0.029 CID_10688629 0.063 0.04 CID_18986923 0.059 0.044 CID_71374942 | CID_10688629 | |
| 0.084 | 0.112 | 0.111 | Proteasome inhibitor | 0.096 0.093 CID_10688629 0.111 0.074 CID_10710332 | CID_10710332 | |
| 0.069 | 0.097 | 0.132 | HIV-1 integrase (Overall Integration) inhibitor | 0.132 0.033 CID_10688629 | CID_10688629 | |
| 0.055 | 0.083 | 0.088 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.08 0.051 CID_10688629 0.085 0.047 CID_18986923 0.088 0.044 CID_71374942 | CID_71374942 | |
| 0.121 | 0.15 | 0.163 | Hepatoprotectant | 0.163 0.096 CID_10688629 0.163 0.097 CID_18986923 0.158 0.101 CID_71374942 | CID_18986923 | |
| 0.054 | 0.083 | 0.076 | Aminopeptidase I inhibitor | 0.076 0.046 CID_10688629 | CID_10688629 | |
| 0.095 | 0.126 | 0.117 | Alkaline phosphatase inhibitor | 0.117 0.09 CID_10688629 0.116 0.092 CID_18986923 0.114 0.093 CID_71374942 | CID_10688629 | |
| 0.07 | 0.101 | 0.09 | NADH dehydrogenase inhibitor | 0.09 0.056 CID_10688629 0.081 0.073 CID_18986923 | CID_10688629 | |
| 0.03 | 0.062 | 0.058 | Cannabinoid CB2 receptor antagonist | 0.058 0.031 CID_10710332 | CID_10710332 | |
| 0.045 | 0.078 | 0.074 | Sphingosine kinase inhibitor | 0.074 0.021 CID_10688629 0.054 0.052 CID_18986923 0.059 0.041 CID_10710332 | CID_10688629 | |
| 0.017 | 0.051 | 0.042 | Sirtuin 2 inhibitor | 0.042 0.016 CID_10710332 | CID_10710332 | |
| 0.118 | 0.152 | 0.145 | Interleukin 6 antagonist | 0.145 0.097 CID_10688629 0.136 0.113 CID_18986923 0.136 0.114 CID_71374942 | CID_10688629 | |
| 0.124 | 0.158 | 0.135 | Heat shock protein 70 antagonist | 0.135 0.094 CID_10688629 0.133 0.105 CID_18986923 0.133 0.104 CID_71374942 | CID_10688629 | |
| 0.028 | 0.063 | 0.053 | NMDA receptor subunit 3B antagonist | 0.053 0.023 CID_10688629 0.047 0.028 CID_18986923 0.048 0.027 CID_71374942 | CID_10688629 | |
| 0.037 | 0.072 | 0.047 | Bombesin 2 receptor antagonist | 0.047 0.038 CID_10710332 | CID_10710332 | |
| 0.064 | 0.1 | 0.082 | Glutathione S-transferase inhibitor | 0.082 0.057 CID_10688629 | CID_10688629 | |
| 0.085 | 0.121 | 0.096 | TRPA1 agonist | 0.096 0.095 CID_71374942 | CID_71374942 | |
| 0.068 | 0.104 | 0.117 | Alcohol dehydrogenase inhibitor | 0.117 0.037 CID_10688629 0.101 0.051 CID_18986923 0.097 0.056 CID_71374942 | CID_10688629 | |
| 0.096 | 0.131 | 0.127 | Protein kinase stimulant | 0.119 0.094 CID_10688629 0.127 0.086 CID_18986923 0.121 0.091 CID_71374942 | CID_18986923 | |
| 0.078 | 0.116 | 0.093 | Phosphodiesterase 6D inhibitor | 0.093 0.067 CID_10688629 | CID_10688629 | |
| 0.036 | 0.073 | 0.056 | Prostaglandin EP2 antagonist | 0.056 0.045 CID_10710332 | CID_10710332 | |
| 0.078 | 0.116 | 0.152 | DNA polymerase I inhibitor | 0.152 0.048 CID_10688629 0.12 0.068 CID_18986923 0.115 0.072 CID_71374942 0.119 0.069 CID_10710332 | CID_10688629 | |
| 0.215 | 0.254 | 0.337 | Cyclophilin D inhibitor | 0.337 0.133 CID_10688629 0.261 0.2 CID_18986923 0.252 0.211 CID_71374942 0.298 0.164 CID_10710332 | CID_10688629 | |
| 0.044 | 0.083 | 0.065 | Purinergic P2X1 antagonist | 0.065 0.036 CID_10688629 | CID_10688629 | |
| 0.08 | 0.119 | 0.098 | Alkylator | 0.098 0.091 CID_18986923 | CID_18986923 | |
| 0.004 | 0.046 | 0.01 | Beta 3 adrenoreceptor agonist | 0.01 0.009 CID_10710332 | CID_10710332 | |
| 0.059 | 0.103 | 0.121 | NMDA receptor antagonist | 0.121 0.035 CID_10688629 0.094 0.051 CID_18986923 0.097 0.049 CID_71374942 | CID_10688629 | |
| 0.128 | 0.173 | 0.157 | Platelet antagonist | 0.157 0.137 CID_10688629 | CID_10688629 | |
| 0.036 | 0.081 | 0.063 | Alpha 1 adrenoreceptor agonist | 0.063 0.034 CID_10710332 | CID_10710332 | |
| 0.049 | 0.094 | 0.104 | Glutamate decarboxylase inhibitor | 0.104 0.027 CID_10688629 0.074 0.05 CID_18986923 0.07 0.054 CID_71374942 | CID_10688629 | |
| 0.02 | 0.066 | 0.042 | NMDA receptor subunit 3A antagonist | 0.042 0.024 CID_10688629 0.034 0.03 CID_18986923 0.035 0.029 CID_71374942 | CID_10688629 | |
| 0.072 | 0.118 | 0.099 | Anabolic | 0.099 0.064 CID_10688629 0.09 0.079 CID_18986923 | CID_10688629 | |
| 0.161 | 0.209 | 0.191 | Transcription factor STAT inhibitor | 0.191 0.151 CID_10688629 | CID_10688629 | |
| 0.053 | 0.103 | 0.072 | GABA aminotransferase inhibitor | 0.072 0.057 CID_10688629 0.067 0.066 CID_71374942 | CID_10688629 | |
| 0.031 | 0.083 | 0.047 | Acyl-CoA dehydrogenase inhibitor | 0.047 0.046 CID_10688629 | CID_10688629 | |
| 0.027 | 0.08 | 0.044 | Sphingosine kinase 1 inhibitor | 0.044 0.024 CID_10688629 | CID_10688629 | |
| 0.055 | 0.111 | 0.074 | Keratolytic | 0.072 0.061 CID_10688629 0.074 0.058 CID_18986923 0.073 0.06 CID_71374942 | CID_18986923 | |
| 0.09 | 0.146 | 0.239 | Peroxidase inhibitor | 0.239 0.05 CID_10688629 0.173 0.068 CID_18986923 0.169 0.069 CID_71374942 | CID_10688629 | |
| 0.022 | 0.082 | 0.051 | NMDA 2A receptor antagonist | 0.051 0.037 CID_10688629 0.05 0.038 CID_10710332 | CID_10688629 | |
| 0.011 | 0.071 | 0.026 | Dopamine D1 agonist | 0.026 0.012 CID_10688629 | CID_10688629 | |
| 0.178 | 0.239 | 0.276 | GABA C receptor rho-3 antagonist | 0.276 0.133 CID_10688629 0.204 0.203 CID_71374942 | CID_10688629 | |
| 0.057 | 0.118 | 0.095 | Aminopeptidase B inhibitor | 0.095 0.068 CID_10688629 | CID_10688629 | |
| 0.057 | 0.118 | 0.076 | Antineoplastic alkaloid | 0.076 0.07 CID_18986923 0.075 0.072 CID_71374942 | CID_18986923 | |
| 0.065 | 0.127 | 0.111 | Protein-tyrosine phosphatase 1B inhibitor | 0.111 0.069 CID_10688629 0.094 0.085 CID_18986923 0.093 0.086 CID_71374942 | CID_10688629 | |
| 0.016 | 0.079 | 0.05 | Catechol O-methyltransferase inhibitor | 0.05 0.009 CID_10688629 | CID_10688629 | |
| 0.074 | 0.142 | 0.094 | Adenylate kinase inhibitor | 0.094 0.079 CID_10688629 | CID_10688629 | |
| 0.064 | 0.135 | 0.079 | Ca(v)3.1 blocker | 0.079 0.062 CID_10710332 | CID_10710332 | |
| 0.14 | 0.211 | 0.187 | Prostaglandin dehydrogenase inhibitor | 0.187 0.166 CID_10688629 | CID_10688629 | |
| 0.009 | 0.083 | 0.033 | Arginase inhibitor | 0.033 0.028 CID_10688629 | CID_10688629 | |
| 0.09 | 0.164 | 0.121 | Diuretic | 0.121 0.104 CID_10688629 | CID_10688629 | |
| 0.05 | 0.127 | 0.075 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.075 0.048 CID_10710332 | CID_10710332 | |
| 0.163 | 0.24 | 0.209 | Caspase 3 stimulant | 0.209 0.156 CID_18986923 0.209 0.156 CID_71374942 | CID_71374942 | |
| 0.07 | 0.148 | 0.094 | Toll-Like receptor 4 antagonist | 0.094 0.08 CID_18986923 0.093 0.082 CID_71374942 | CID_18986923 | |
| 0.063 | 0.144 | 0.109 | Cystathionine beta-synthase inhibitor | 0.106 0.07 CID_10688629 0.109 0.068 CID_18986923 0.106 0.07 CID_71374942 | CID_18986923 | |
| 0.113 | 0.201 | 0.187 | Interleukin agonist | 0.187 0.133 CID_10688629 0.18 0.14 CID_10710332 | CID_10688629 | |
| 0.072 | 0.16 | 0.116 | DOPA decarboxylase inhibitor | 0.116 0.05 CID_10688629 0.102 0.071 CID_18986923 0.096 0.084 CID_71374942 | CID_10688629 | |
| 0.027 | 0.117 | 0.048 | Histamine agonist | 0.048 0.044 CID_10710332 | CID_10710332 | |
| 0.078 | 0.169 | 0.139 | Interleukin 4 antagonist | 0.139 0.06 CID_10688629 0.137 0.063 CID_18986923 0.135 0.066 CID_71374942 | CID_10688629 | |
| 0.013 | 0.107 | 0.059 | Estrogen agonist | 0.059 0.031 CID_18986923 0.055 0.032 CID_71374942 | CID_18986923 | |
| 0.044 | 0.14 | 0.077 | CDC25A inhibitor | 0.077 0.047 CID_10688629 | CID_10688629 | |
| 0.091 | 0.189 | 0.164 | Insulin secretagoues | 0.164 0.061 CID_10710332 | CID_10710332 | |
| 0.048 | 0.148 | 0.09 | Topoisomerase I inhibitor | 0.09 0.079 CID_18986923 0.088 0.081 CID_71374942 | CID_18986923 | |
| 0.082 | 0.182 | 0.142 | Protein-tyrosine phosphatase inhibitor | 0.142 0.088 CID_10688629 0.118 0.115 CID_18986923 0.118 0.115 CID_71374942 | CID_10688629 | |
| 0.055 | 0.155 | 0.108 | Topoisomerase II inhibitor | 0.095 0.091 CID_10688629 0.108 0.078 CID_18986923 0.107 0.079 CID_71374942 | CID_18986923 | |
| 0.035 | 0.136 | 0.06 | CDC25B inhibitor | 0.06 0.051 CID_10688629 | CID_10688629 | |
| 0.115 | 0.219 | 0.143 | Catenin beta inhibitor | 0.142 0.125 CID_18986923 0.143 0.124 CID_71374942 | CID_71374942 | |
| 0.046 | 0.151 | 0.079 | Opioid antagonist | 0.079 0.071 CID_18986923 0.079 0.071 CID_71374942 | CID_71374942 | |
| 0.018 | 0.128 | 0.032 | Estrogen-related receptor beta antagonist | 0.032 0.023 CID_18986923 0.032 0.023 CID_71374942 | CID_71374942 | |
| 0.132 | 0.251 | 0.174 | RNA-directed DNA polymerase inhibitor | 0.174 0.144 CID_10688629 | CID_10688629 | |
| 0.056 | 0.176 | 0.12 | Estrogen receptor beta antagonist | 0.109 0.048 CID_10688629 0.12 0.032 CID_18986923 0.119 0.033 CID_71374942 | CID_18986923 | |
| 0.052 | 0.172 | 0.089 | UDP-glucose 4-epimerase inhibitor | 0.089 0.074 CID_10688629 | CID_10688629 | |
| 0.089 | 0.214 | 0.137 | Dual specificity phosphatase inhibitor | 0.137 0.111 CID_10688629 | CID_10688629 | |
| 0.048 | 0.175 | 0.138 | Creatine kinase inhibitor | 0.138 0.029 CID_10688629 0.086 0.078 CID_18986923 0.084 0.081 CID_71374942 | CID_10688629 | |
| 0.028 | 0.171 | 0.065 | Porphobilinogen synthase inhibitor | 0.065 0.061 CID_10688629 | CID_10688629 | |
| 0.021 | 0.197 | 0.065 | HIV-1 integrase (3'-Processing) inhibitor | 0.065 0.043 CID_10688629 | CID_10688629 | |
| 0.135 | 0.341 | 0.205 | Interleukin 2 agonist | 0.205 0.18 CID_10688629 | CID_10688629 | |
| 0.024 | 0.281 | 0.134 | M18 aspartyl aminopeptidase inhibitor | 0.134 0.06 CID_10688629 | CID_10688629 | |
| 0.023 | 0.316 | 0.065 | HIV-1 integrase inhibitor | 0.065 0.057 CID_10688629 | CID_10688629 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |